The GLP-1 receptor agonist liraglutide improves glucose tolerance and reduces body weight in schizophrenia spectrum disorder patients treated with clozapine or olanzapine

Louise Vedtofte, Julie R. Larsen, Mathilde S. L. Jakobsen, Hans R. Jespersen, Michelle I. Jakobsen, Camilla K. Svensson, Kamuran Koyuncu, Ole Schjerning, Peter S. Oturai, Andreas Kjaer, Jimmi Nielsen, Jens J. Holst, Claus T. Ekstrøm, Christoph U. Correll, Tina Vilsbøll, Anders Fink-Jensen

Research output: Contribution to book/anthology/report/conference proceedingConference abstract in proceedingResearch

Original languageEnglish
Title of host publicationDES Årsmøde 2017 : Abstraktbog
Number of pages2
Publication date2017
Pages53-54
Article number40
Publication statusPublished - 2017
EventDansk Endokrinologisk Selskabs Årsmøde - Esbjerg, Denmark
Duration: 27 Jan 201728 Jan 2017

Conference

ConferenceDansk Endokrinologisk Selskabs Årsmøde
Country/TerritoryDenmark
CityEsbjerg
Period27/01/201728/01/2017

Cite this